ArticleJAMA network open2026
Older Patients and Conservative Kidney Management.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: In the US, dialysis remains the reflexive treatment option for end-stage kidney disease. Conservative kidney management (CKM), a nondialytic pathway, is infrequently utilized despite the burden dialysis often imposes on patients, caregivers, and health care systems. Objective: To examine why older adults choose CKM, how caregivers influence this choice, and how nephrologists support CKM through advance care planning and palliative care referrals. Design, Setting, and Participants: This qualitative study included secondary analysis of clinical notes and visit data from patients, caregivers, and nephrologists in 2 randomized trials in the US collectively spanning 2019 to 2024. Descriptive and qualitative methods were used to examine decision-making among older adults who chose CKM in CKD-EDU (Chronic Kidney Disease Enhanced Dialysis Education) and DIAL-SDM (Shared Decision Making in Dialysis), based on coaching visit data and nephrology clinic notes collected from January 10, 2019, to July 18, 2024. The secondary analyses for this study were performed May 19, 2024, to February 7, 2025. Main Outcomes and Measures: Main outcomes were patients' reasons for choosing CKM; caregiver and nephrologist support for CKM; and frequency of advance care planning and palliative care referrals. Results: Of the 118 patients enrolled in the 2 trials, 35 chose CKM (mean [SD] age, 82 [5.9] years; 19 female [54.3%]; 8 Black [22.9%], 26 White [74.3%], 1 other [2.8%]). Qualitative analysis revealed the most common reasons for choosing CKM: (1) avoiding anticipated burdens of dialysis to maintain quality of life, (2) current poor health making CKM a logical choice, (3) witnessing the benefits and burdens of dialysis and CKM in loved ones, and (4) avoiding overmedicalization at the end of life. Caregivers often preferred life-prolonging therapies but typically aligned with patients' wishes once those wishes were known. Nephrologists frequently framed dialysis as the reflexive option, sometimes questioned goal-concordant CKM choices, and rarely initiated advance care planning or palliative care referrals. Conclusions and Relevance: In this qualitative study of patients, caregivers, and nephrologists, support for CKM was limited, despite patients consistently citing reasons for choosing CKM. Expanding CKM will require nephrologist training, caregiver-inclusive decision-making, institutional CKM pathways, and policies that incentivize its use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.